BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers
brief summary
This is a randomized, double-blinded, vehicle-controlled, parallel, phase II study to evaluate the efficacy and safety of topical BB-101 for the treatment of diabetic lower leg and foot ulcer.
detailed description
This is a randomized, double-blinded, vehicle-controlled, parallel, phase II study to evaluate the efficacy and safety of topical BB-101 for the treatment of diabetic lower leg and foot ulcer.
All subjects will receive standard-of-care ulcer treatment from screening through the last study visit.
The study will be conducted at multiple investigational sites located in Taiwan. Additional sites and countries may be added during the course of the study if required.
official title
Phase II Study to Evaluate the Efficacy and Safety of Topical BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers